ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of the Safety and Pharmacokinetics of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients With Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01427699
Recruitment Status : Completed
First Posted : September 1, 2011
Last Update Posted : October 31, 2012
Sponsor:
Information provided by (Responsible Party):
XBiotech, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2012
  Study Completion Date : No date given